Patents by Inventor Francois Alhenc-Gelas

Francois Alhenc-Gelas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and Pharmaceutical Compositions for Prevention or Treatment of Ischemia Related Organ Damage
    Publication number: 20150105329
    Abstract: The present invention relates to methods and compositions for the prevention or treatment of ischemia related organ damage.
    Type: Application
    Filed: March 26, 2013
    Publication date: April 16, 2015
    Inventors: Francois Alhenc-Gelas, Nadine Bouby, Fernand Junior Gobeil, Ronan Roussel, Ludovic Waeckel, Louis Potier
  • Nucleic acid coding for the human angiotensin converting enzyme (ACE), and its uses, especially for the in vitro diagnosis of arterial hypertension
    Patent number: 5480793
    Abstract: The invention relates to the cloning and sequencing of the nucleic acid coding for the human ACE as well as the determination of the peptide chain corresponding to the ACE and of active peptide fragments which derive from it.Another subject of the invention is the utilization of the above-mentioned polypeptides for the implementation of in vitro diagnostic methods for hypertension and for the design of new inhibitors of the ACE.The invention also relates to the utilization of the nucleotide probes of the invention for the in vitro screening of the polymorphisms of the gene coding for the ACE.
    Type: Grant
    Filed: August 12, 1994
    Date of Patent: January 2, 1996
    Assignee: Institut National De La Sante Et De La Recherche Medicale
    Inventors: Florent Soubrier, Francois Alhenc-Gelas, Christine Hubert, Pierre Corvol
  • Nucleic acid coding for the human angiotensin converting enzyme (ACE), and its uses, especially for the in vitro diagnosis of arterial hypertension
    Patent number: 5359045
    Abstract: The invention relates to the cloning and sequencing of the nucleic acid coding for the human ACE as well as the determination of the peptide chain corresponding to the ACE and of active peptide fragments which derive from it.Another subject of the invention is the utilization of the above-mentioned polypeptides for the implementation of in vitro diagnostic methods for hypertension and for the design of new inhibitors of the ACE.The invention also relates to the utilization of the nucleotide probes of the invention for the in vitro screening of the polymorphisms of the gene coding for the ACE.
    Type: Grant
    Filed: May 23, 1990
    Date of Patent: October 25, 1994
    Assignee: Institut National de la Sante et de la Recherche Medicale
    Inventors: Florent Soubrier, Francois Alhenc-Gelas, Christine Hubert, Pierre Corvol